Amitriptyline in migraine prophylaxis
J. R. Couch and R. S. Hassanein
In a controlled trial of amitriptyline hydrochloride in migraine
prophylaxis, 100 patients received placebo for a four-week baseline period
and then were randomized in double-blind fashion to therapy with
amitriptyline (47 subjects) or placebo (53 subjects) for another four to
eight weeks. Subjects received up to four 25-mg tablets of amitriptyline
hydrochloride or identical placebo per day. Comparing the first and second
four-week periods for each patient, the conditions of 55.3% of
amitriptyline subjects as opposed to 34.0% of placebo subjects were greater
than or equal to 50% improved and the difference between amitriptyline and
placebo response rates was significant (P less than .05). Nondepressed
subjects with severe migraine and depressed subjects with less severe
migraine responded best to amitriptyline, whereas depressed subjects with
severe migraine had little headache relief. Amitritryline is an effective
antimigraine agent and the antimigraine effect seems relatively independent
of antidepressant activity.
Migraine prevention
Dodick and Silberstein
PN 2007;7:383-393.
ABSTRACT
| FULL TEXT
Prednisolone does not reduce withdrawal headache: A randomized, double-blind study
Boe et al.
Neurology 2007;69:26-31.
ABSTRACT
| FULL TEXT
A Practical Approach to Headache Treatment
Tucker
Journal of Pharmacy Practice 2007;20:123-136.
ABSTRACT
Pediatric Migraine: Recognition and Treatment
Hershey and Winner
JAOA: Journal of the American Osteopathic Association 2005;105:2S-8S.
ABSTRACT
| FULL TEXT
Topiramate in Migraine Prevention: Results of a Large Controlled Trial
Silberstein et al.
Arch Neurol 2004;61:490-495.
ABSTRACT
| FULL TEXT
Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Snow et al.
ANN INTERN MED 2002;137:840-849.
ABSTRACT
| FULL TEXT
Managing migraine
DTB 1998;36:41-44.
ABSTRACT
| FULL TEXT
Drug Therapy of Migraine
Welch
NEJM 1993;329:1476-1483.
FULL TEXT
The psychopharmacology of chronic pain
Walsh
J Psychopharmacol 1991;5:364-369.